Unlock instant, AI-driven research and patent intelligence for your innovation.

Pyrazole compound and its preparation method and use

A compound, pyrazole technology, applied in the field of medicine and medicinal chemical synthesis, can solve the problems of rapid mutation, acceleration and urgency of influenza virus

Active Publication Date: 2021-06-04
EAST CHINA UNIV OF SCI & TECH
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In summary, in view of the fact that the currently marketed neuraminidase inhibitors oseltamivir and peramivir have corresponding drug-resistant virus strains, and at the same time, influenza viruses mutate rapidly and tend to accelerate, so the development has a certain New neuraminidase inhibitors with resistance to drug resistance and good oral availability are urgently needed

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pyrazole compound and its preparation method and use
  • Pyrazole compound and its preparation method and use
  • Pyrazole compound and its preparation method and use

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0033] Synthesis of N-(substituted benzisothiazole)-2(3H)-carboxamide (A)

[0034]

[0035] Step 15 - Synthesis of Amylhydantoin (a1)

[0036] Add hydantoin (1g, 10mmol) and 3-pentanone (1.29g, 15mmol) in sequence in a single-necked bottle, stir, heat up to 55°C, add ethanolamine (0.475g, 7.8mmol) dropwise, and heat up to 115 ℃ nitrogen protection reflux reaction for 6-10 hours, the reaction is completed, cooled to room temperature, the reaction system is brownish yellow, with a small amount of white crystals precipitated. Subsequently, about 2 times the volume of water was added to the reaction system, and the pH was adjusted to 4 with 6M hydrochloric acid, and a large amount of white crystals were precipitated in the reaction system. Filter, wash the filter cake with water, and dry to obtain a 11.04 g white crystalline solid with a yield of 62%.

[0037] 1 H NMR (400MHz, DMSO-d 6)δppm10.81(s,1H),9.76(s,1H),2.60(q,J=7.4Hz,2H),2.14(q,J=7.6Hz,2H),0.97(t,J=7.6Hz, 6H); 1...

Embodiment 2

[0067] Synthesis of 4-(p-toluenesulfonyloxymethyl)-2-oxazolidinone (B)

[0068]

[0069] Step 12-Synthesis of methyl oxazolidinone-4-carboxylate (b-1)

[0070] Weigh serine methyl ester hydrochloride (800mg, 5.16mmol) in a two-necked bottle, add 6mL of anhydrous dichloromethane to the reaction solution under nitrogen protection, stir to dissolve completely, add redistilled triethylamine under ice bath stirring, After reacting for 15 minutes, under the protection of nitrogen, 2 mL of anhydrous dichloromethane mixed solution of triphosgene (1.531 g, 5.16 mmol) was added dropwise. The reaction is almost complete. Add 20 mL of diethyl ether to the reaction system, freeze in the refrigerator for 30 minutes, and then filter, then freeze the filtrate in the refrigerator, filter, collect the filtrate, concentrate, and purify by silica gel column chromatography (petroleum ether: ethyl acetate = 1:2) to obtain Pale yellow oil b-1 627mg, yield 84%.

[0071] 1 H NMR (400MHz, CDCl ...

Embodiment 3

[0080] Synthesis of 4-biphenylbenzyl bromide (C)

[0081]

[0082] The first step: the preparation of 4-biphenyl benzyl alcohol (c1)

[0083] In a 50mL round-bottomed flask, dissolve 4-biphenylcarbaldehyde (365mg, 2mmol) in 10mL of methanol, add sodium borohydride (151mg, 4mmol) in batches under ice-bath conditions, and then turn the reaction system to room temperature for 45 minutes , TLC monitors that the reaction is complete. After the solvent was removed from the reaction system, 10 mL of dichloromethane was added, washed with water (2×10 mL), the organic layer was washed with saturated brine, dried over anhydrous sodium sulfate, filtered, and concentrated to obtain a yellow powdery crude product c1, which could be used for direct injection into the next step.

[0084] 1 H NMR (CDCl 3 ,400MHz)δ7.62-7.59(m,4H),7.48-7.43(m,4H),7.39-7.34(m,1H),4.74(br,2H).

[0085] The second step: the preparation of 4-biphenylbenzyl bromide (C)

[0086] In a 50mL round bottom flask, ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a pyrazole compound with neuraminidase inhibitory activity, a preparation method and a pharmaceutical application thereof. It specifically relates to the compound represented by formula (I), its pharmaceutically acceptable salts, isomers and prodrugs, wherein the definition of each group is as described in the description. The present invention also relates to these compound pharmaceutical preparations, pharmaceutical compositions and their application in treating diseases caused by influenza virus infection. The pyrazole compound of the present invention has good inhibitory effect on cells infected by H1N1 influenza A virus.

Description

technical field [0001] The invention relates to the field of medical technology, in particular to the field of chemical synthesis of medicines, and specifically refers to a pyrazole compound and its preparation method and application. Background technique [0002] Influenza A virus (Influenza A virus) can be transmitted between humans or between humans and animals through droplets, and is the main pathogenic factor of seasonal or pandemic influenza. Because influenza A virus is prone to gene point mutation and gene recombination, which leads to antigenic drift or even antigenic transformation, the virus continues to mutate and evolve, and highly virulent virus strains may appear without warning, causing moderate and severe influenza in local areas. Small-scale epidemics or even global pandemics, such as H1N1 (Spanish flu) in 1918, H2N2 (Asian flu) in 1957, H3N2 (Hong Kong flu) in 1968, H5N1 (bird flu) in 2005, H1N1 (swine flu) in 2009 And H7N9 (bird flu) in 2013 and so on. ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D413/06C07D233/90A61K31/422A61K31/415A61P31/16
CPCA61P31/16C07D233/90C07D413/06
Inventor 王卫陈晓蓓沈祖源钱彭飞耿慧慧罗凡
Owner EAST CHINA UNIV OF SCI & TECH